Johannes T H Nielen

5PUBLICATIONS
19CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMolecular targetsPharmacogenomicsMetabolic medicineMicrobial ecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 09, 2026
Creating Awareness of preScribing Cascades and Managing Adverse Drug Effects (CASC-ADE) Tool: Appraisal by Future End Users.

|Jul 17, 2025
Prediction of glycaemic control and quality of life in people with type 2 diabetes using glucose-lowering drugs with machine learning-The Maastricht study.

Nikki C C Werkman, Johannes T H Nielen, José Tapia-Galisteo

|Jul 02, 2024
Incretin-based therapy and the risk of diabetic foot ulcers and related events.

Nikki C C Werkman, Johanna H M Driessen, Olaf H Klungel

|Jan 11, 2024
Disease severity-based subgrouping of type 2 diabetes does not parallel differences in quality of life: the Maastricht Study.

Nikki C C Werkman, Gema García-Sáez, Johannes T H Nielen

|May 26, 2018
The Association Between β-Blocker Use and Cardiorespiratory Fitness: The Maastricht Study.

Johannes T H Nielen, Frank de Vries, Jeroen H P M van der Velde

Pageof 1

Frequent Collaborators

3 joint publications

Nikki C C Werkman

3 joint publications

Coen D A Stehouwer

1 joint publications

Jeroen H P M van der Velde

1 joint publications

Gema García-Sáez